These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15888073)

  • 1. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients.
    Kasiske BL;
    Am J Transplant; 2005 Jun; 5(6):1576. PubMed ID: 15888073
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: lessons to be learnt from the assessment of Lescol in renal transplantation (ALERT) trial.
    Holdaas H; Fellström B; Jardine AG;
    Am J Transplant; 2005 Jun; 5(6):1574-5. PubMed ID: 15888072
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.
    Kasiske B; Cosio FG; Beto J; Bolton K; Chavers BM; Grimm R; Levin A; Masri B; Parekh R; Wanner C; Wheeler DC; Wilson PW;
    Am J Transplant; 2004; 4 Suppl 7():13-53. PubMed ID: 15027968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvastatin plus fish oil are more effective on cardiovascular risk factors than fluvastatin alone.
    Singer P
    Prostaglandins Leukot Essent Fatty Acids; 2005 May; 72(5):379-80. PubMed ID: 15850720
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of dyslipidemia in renal disease and transplantation.
    Zolezzi M
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):129-36. PubMed ID: 16903617
    [No Abstract]   [Full Text] [Related]  

  • 6. Does time of onset of therapy alter the protective cardiovascular effect of fluvastatin after renal transplantation?
    Morales JM
    Nat Clin Pract Nephrol; 2005 Dec; 1(2):78-9. PubMed ID: 16932372
    [No Abstract]   [Full Text] [Related]  

  • 7. [High therapeutic effect and safety of fluvastatin].
    Pharm Unserer Zeit; 2003; 32(6):516-7. PubMed ID: 14639833
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
    Corsini A; Holdaas H
    Ren Fail; 2005; 27(3):259-73. PubMed ID: 15957541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience.
    Jardine A; Holdaas H
    J Clin Pharm Ther; 1999 Dec; 24(6):397-408. PubMed ID: 10651972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of fluvastatin in cardiovascular risk management.
    McDonald KJ; Jardine AG
    Expert Opin Pharmacother; 2008 Jun; 9(8):1407-14. PubMed ID: 18473714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids and hemostasis in kidney allograft recipients treated with fluvastatin (Lescol) for 3 months.
    Malyszko JS; Malyszko J; Mysliwiec M
    Transplant Proc; 2000 Sep; 32(6):1344-6. PubMed ID: 10995974
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data.
    Holdaas H; Fellström B; Holme I; Nyberg G; Fauchald P; Jardine A; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Weinreich T; Olsson AG; Pedersen TR; Benghozi R; Hartmann A;
    J Cardiovasc Risk; 2001 Apr; 8(2):63-71. PubMed ID: 11324372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin in patients undergoing vascular surgery.
    Gualandro DM; Calderaro D; Caramelli B
    N Engl J Med; 2009 Nov; 361(22):2186; author reply 2187-8. PubMed ID: 19940303
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.
    Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T
    Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluvastatin in patients undergoing vascular surgery.
    Landesberg G; Beattie SW; Alpert JS
    N Engl J Med; 2009 Nov; 361(22):2186-7; author reply 2187-8. PubMed ID: 19950408
    [No Abstract]   [Full Text] [Related]  

  • 17. Current concepts in the management of hypercholesterolemia with an update on fluvastatin. Introduction.
    Cohen JD
    Am J Cardiol; 1996 Sep; 78(6A):1-3. PubMed ID: 8875968
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.
    Türk S; Yildiz A; Tükek T; Akkaya V; Aras U; Türkmen A; Uras AR; Sever MS
    Int Urol Nephrol; 2001; 32(4):713-6. PubMed ID: 11989571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
    Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
    Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.
    Robertsen I; Asberg A; Granseth T; Vethe NT; Akhlaghi F; Ghareeb M; Molden E; Reier-Nilsen M; Holdaas H; Midtvedt K
    Transplantation; 2014 Jun; 97(12):1266-71. PubMed ID: 24521776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.